Press Release

Entrepreneurial Western Herbalist, Innovative Health & Wellness Consumer Product Formulator, and Proven Healthcare Sector Business Builder Joins Highly Diversified Team of Advisors

Miami, FL – September 15, 2023 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, announced today that it has appointed Alicia R. Crockett to the Company’s advisory board.

“Alicia’s deep well of experience managing, training, and guiding individuals and teams across a broad array of diverse industries including healthcare, marketing, consumer product innovation, and education stands to bring significant expertise to our burgeoning advisory board,” said Darren Minton, CEO of Smart for Life. “Every aspect of Smart for Life’s business is strengthened from the collective and diverse experience found within our growing team of advisors. We are pleased to have Alicia join our organization as we continue exploring emerging opportunities within several fields that overlap with her decades of experience.”

“I’m passionate about people and nature, and I am in constant search of discovering new ways to bring the two together in pursuit of health, wellness, and personal transformation while remaining in positive relationship with the world around us,” said Ms. Crockett. “Whether utilizing my expertise as a certified Clinical Western Herbalist and teacher to formulate all-natural Health & Wellness products for high-end national brands or directing my organizational and leadership skills into building a new clinical business from inception to millions of dollars in revenue, I am always seeking new ways of improving people’s lives through innovation in healthcare and the natural health and wellness sectors.”

“We count on the industry expertise of our seasoned advisors to illuminate new trends both in products and markets,” Mr. Minton continued. “Our executive team and directors look forward to collaborating with Alicia and the other members of the advisory board to help us shape the direction – and maximize the potential for the success – of Smart for Life’s future product offerings.”

About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on health and wellness. Structured as a publicly held global holding company, the Company is executing a Buy-and-Build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues by the fourth quarter of 2026. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition and Ceautamed Worldwide. For more information about Smart for Life, please visit: www.smartforlifecorp.com.

Video regarding the Company’s manufacturing facility at Bonne Santé Natural Manufacturing is available at: www.bonnesantemanufacturing.com/video.

Investor material and a Fact Sheet with additional information about Smart for Life is available at: www.smartforlifecorp.com/investor-center.

Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Disclaimer
The information provided in this press release is intended for general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. This information is not intended to diagnose, treat, cure or prevent any disease.

Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com

Prominent Health & Wellness Sector Thought Leader and Author

Miami, FL – August 31, 2023 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, announced today that it has appointed Cindy Brynteson to the Company’s advisory board.

“Cindy has devoted her life to nutrition and fitness and is an acknowledged leader and teacher in the field,” stated Darren Minton, CEO of Smart for Life. “As a successful author, her recent book, ‘You Can Live Like This,’ represents a definitive guide to weight loss and maintaining a healthy, balanced lifestyle. Cindy has established herself as leader in the business and health communities, teaching Health & Wellness for almost 50 years.”

“I am excited to join the Smart for Life advisory board with its diverse background of members and outstanding portfolio of products,” said Cindy Brynteson. “Throughout my career in the Health & Wellness industry, one of my core principles is investigating the underlying root causes of health issues and supporting the body to repair itself naturally, as opposed to just treating symptoms. I look forward to working with the Smart for Life team and continuing to spread the benefits of healthy living.”

Mr. Minton concluded, “Smart for Life benefits greatly from the collective and diverse experience found within our advisory board. Not only does the advisory board provide strategic insights based on the unique backgrounds of its members, but the dynamic collaboration supports our management and Board of Directors as we execute on our mission and explore emerging opportunities. Cindy brings a significant amount of experience through her years of advancing health and balance in all aspects of life and we are pleased to have her join our team.”

About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on health and wellness. Structured as a publicly held global holding company, the Company is executing a Buy-and-Build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues by the fourth quarter of 2026. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition and Ceautamed Worldwide. For more information about Smart for Life, please visit: www.smartforlifecorp.com.

Video regarding the Company’s manufacturing facility at Bonne Santé Natural Manufacturing is available at: www.bonnesantemanufacturing.com/video.

Investor material and a Fact Sheet with additional information about Smart for Life is available at: www.smartforlifecorp.com/investor-center.

Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Disclaimer
The information provided in this press release is intended for general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. This information is not intended to diagnose, treat, cure or prevent any disease.

Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com

Benson Provides Deep Nutraceutical Industry Business Experience to the Highly Diversified Board

Miami, FL – August 24, 2023 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, announced today that it has appointed Stuart Benson, JD to the Company’s recently formed high-level advisory board.

“Stuart has a long and successful career in a broad array of businesses, with the last 20 years focused on the nutraceutical industry and more specifically the growth and success of Ceautamed Worldwide, Smart for Life’s most recent acquisition,” stated Darren Minton, Smart for Life’s CEO.

“Throughout our time together, I’ve gotten to know Darren Minton, the Company’s CEO, A.J. Cervantes, the Company’s Chairman and Alan Bergman, the Company’s CFO and have developed deep respect for the entire Smart for Life team,” said Mr. Benson. “The Company is not only aggressively ramping up its M&A activities, it is now targeting significantly larger and more profitable companies. For these reasons, I’m excited to join the Company’s advisory board.”

Mr. Minton concluded, “A highly diversified advisory board such as this supports our management team in gaining new insights and advice to solve business problems or explore new opportunities. The advisory board has not been formed to make important company decisions, but to provide strategic thinking and analysis to support the management and the Board of Directors.”

About Stuart Benson, JD
Mr. Benson is a former principal of Ceautamed Worldwide, LLC, owner of the Greens First line of brand products, Smart for Life’s acquisition completed on July 28, 2022. Mr. Benson was also the Chief Executive Officer of Wellness Watchers Global, LLC. Mr. Benson served as the Chairman and Chief Executive Officer of Custom Food Concepts, Inc. from 1997 to 2001, a company engaged in real estate and franchising. He also served as Executive Vice President of Vital Living Inc. in 2001 and 2002 and served as its Chief Executive Officer since 2005. He served as Chairman, President and Chief Executive Officer of Nathan’s Famous, Inc. and the Great Earth Vitamin Store chain. During his tenure at Nathan’s Famous, the company expanded from 14 units to more than 300, including locations at interstate highways and airports. During Mr. Benson’s tenure at the Great Earth Vitamin Store chain, it grew to approximately 150 full-service vitamin retail stores throughout the U.S. and became the second largest vitamin store in the U.S.

About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on health and wellness. Structured as a publicly held global holding company, the Company is executing a Buy-and-Build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues by the fourth quarter of 2026. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition and Ceautamed Worldwide. For more information about Smart for Life, please visit: www.smartforlifecorp.com.

Video regarding the Company’s manufacturing facility at Bonne Santé Natural Manufacturing is available at: www.bonnesantemanufacturing.com/video.

Investor material and a Fact Sheet with additional information about Smart for Life is available at: www.smartforlifecorp.com/investor-center.

Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com

Balance Sheet Transformation Includes Conversion of Over $5.8 Million Debt to Equity

Stockholders’ Equity Improves from Deficit of $2.4 Million to Equity of $4.6 Million

Loss for the Six-Month Period Decreases from $20.0 Million to $8.5 Millon

Miami, FL – August 23, 2023 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, today provided a business update and reported financial results for the three months ended June 30, 2023.

“We continue to advance our operations and have made significant progress growing our brands. During the quarter, we launched a new line of Sports Illustrated protein bars. We made these bars to address a growing demand for clean and nutritional products. The bars are non-GMO, cold-pressed, with no sucralose and no preservatives, and include options that are gluten-free. We look forward to launching them in select markets this quarter. Recently, we entered into a distribution agreement with Boxout, a national distributor of medical, rehabilitation, and health & wellness products, for nationwide distribution of our proprietary Sports Illustrated Nutrition products through Boxout’s distribution channels to sports and fitness chains across North America. We look forward to working with Boxout and leveraging their broad distribution network.”

“We also executed a comprehensive Canadian distribution agreement with Two Hands Corporation for our nutritional food products. We expect this agreement to significantly expand our geographic reach by adding additional distribution partners and retail channels in Canada. Expansion of our sales in both domestic and international markets is a key component of our growth strategy as part of our stated goal of reaching $100 million in revenue. Although our revenues decreased in Q2 2023, due to cash constraints and fulfillment delays, we are confident that as we execute on the growing sales pipeline and purchase orders, our sales should rapidly increase.  Notably, during the quarter, we enhanced our balance sheet, by converting over $5.8 million of debt to equity. We also converted $1.2 million of deferred executive and board compensation to equity as well.”

“We continue to execute on our “Buy and Build” strategy by acquiring cash flow positive companies at attractive multiples. Towards that end, we expect to close the eCommerce nutraceuticals company acquisition in the next several weeks. The target is currently generating estimated revenue in excess of $10 million, with over $2 million of EBITDA for the trailing twelve months. Overall, we believe we are well positioned to achieve strong revenue growth and drive significant value for our shareholders.”

Financial Results
Revenue was $2.3 million for the three months ended June 30, 2023, compared to $4.3 million for the three months ended June 30, 2022. The decrease in revenue was primarily due to a delay in financing, which led to a temporary delay in production. Gross profit was approximately $742 thousand for the three months ended June 30, 2023, compared to $1.8 million for the same period last year. Net loss attributable to common shareholders was $4.2 million for the three months ended June 30, 2023, as compared to $3.5 million for the three months ended June 30, 2022.

Revenue was $4.7 million for the six months ended June 30, 2023 compared to $8.7 million for the six months ended June 30, 2022. Gross profit was $1.6 million for the six months ended June 30, 2023 compared to $3.3 million for same period last year. Net loss attributable to common shareholders was $8.5 million for the six months ended June 30, 2023 compared to $20.2 million for same period last year.

EBITDA and Adjusted EBITDA
The Company reported Adjusted EBITDA loss of $2.6 million in Q2 2023, as compared to Adjusted EBITDA loss of $1.9 million in Q2 2022. For the six months ended June 30, 2023, the Company reported Adjusted EBITDA loss of $4.5 million versus an Adjusted EBITDA loss of $4.5 million for the same period last year. The Company defines EBITDA as earnings before interest, taxes and depreciation and amortization. The Company defines Adjusted EBITDA as earnings before related party consulting fees, stock-based compensation, stock issued for services, bad debt expense, IPO related expenses, impairment of intangible assets, and gain on debt extinguishment.  Both EBITDA and Adjusted EBITDA are not measures of performance calculated in accordance with Generally Accepted Accounting Principles in the United States of America (“GAAP”), and should not be considered in isolation of, or as a substitute for, earnings as an indicator of operating performance or cash flows from operating activities as a measure of liquidity. The Company believes the presentation of EBITDA and Adjusted EBITDA is relevant and useful by enhancing the readers’ ability to understand the Company’s operating performance. The Company’s management utilizes EBITDA and Adjusted EBITDA as means to measure performance. The Company’s measurements of EBITDA and Adjusted EBITDA may not be comparable to similar titled measures reported by other companies. The table below reconciles EBITDA and Adjusted EBITDA, both non-GAAP measures, to GAAP numbers for net loss for net loss for the three and six months ended June 30, 2023 and 2022.

About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on health and wellness. Structured as a publicly held global holding company, the Company is executing a Buy-and-Build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues by the fourth quarter of 2026. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition and Ceautamed Worldwide. For more information about Smart for Life, please visit: www.smartforlifecorp.com.

Video regarding the Company’s manufacturing facility at Bonne Santé Natural Manufacturing is available at: www.bonnesantemanufacturing.com/video.

Investor material and a Fact Sheet with additional information about Smart for Life is available at: www.smartforlifecorp.com/investor-center.

Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com

Review Includes Interactive Links to Company’s Major Announcements

Miami, FL – August 7, 2023 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, is releasing a recap of the Company’s activities year-to-date.

“Given all of the significant events that have occurred with our company since the beginning of the year, we thought it beneficial to recap those events for our shareholders and those considering becoming shareholders,” stated Darren Minton, Smart for Life’s CEO. “We believe our proactive Buy and Build strategy is working, as we have now completed five major acquisitions since our formation. With recognizable brands, industry-leading products, loyal customers, and a full range of world-class service offerings, Smart for Life is positioned to bring health and wellness to customers around the world.”

Click on links below to read the entire release:

• Smart for Life Inaugurates High Level Advisory Board
• Smart for Life Announces Greens First Product Line Now Available on Kroger’s Vitacost.com
• Smart for Life Executes Broad Agreement with Boxout Health for Nationwide Distribution of Sports Illustrated Nutrition Line
• Smart for Life Announces Execution of Comprehensive Canadian Distribution Agreement for its Nutritional Food Products
• Smart for Life Releases CEO Statement on Successful Recapitalization
• Smart for Life Announces Successful Debt Refinancing as Part of Company’s Balance Sheet Transformation
• Smart for Life Announces Launch of New Line of Sports Illustrated Protein Bars
• Smart for Life Executes Strategic Agreement with CloudKitchens for Rapid Local Delivery of its High Protein Ice Cream Across Major US Markets
• Smart for Life Announces Planned Launch of Greens First Children’s Chewable Multivitamins
• Smart for Life Launches Proprietary New Line of High Protein Ice Cream
• Smart for Life Provides Update on Pending Acquisition
• Smart for Life Releases High Impact TV Commercial
• Smart for Life Enters into New Distribution Agreement with BOXOUT®, to Expand Distribution of Greens First Product Line
• Smart for Life CEO Issues Year-End Letter to Shareholders

About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on health and wellness. Structured as a publicly held global holding company, the Company is executing a Buy-and-Build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues by the fourth quarter of 2026. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition and Ceautamed Worldwide. For more information about Smart for Life, please visit: www.smartforlifecorp.com.

Video regarding the Company’s manufacturing facility at Bonne Santé Natural Manufacturing is available at: www.bonnesantemanufacturing.com/video.

Investor material and a Fact Sheet with additional information about Smart for Life is available at: www.smartforlifecorp.com/investor-center.

Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com

Miami, FL – August 3, 2023 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, today announced that Darren Minton, Chief Executive Officer of Smart For Life, will be presenting at the H.C. Wainwright 25th Annual Global Investment Conference which is being held September 11th – 13th, 2023 at the Lotte New York Palace Hotel in New York City.

The presentation will be available to registered conference attendees via the conference portal. Additionally, a webcast of the Company’s presentation will be available for replay on the Investor Relations section of Smart for Life’s website at: https://smartforlifecorp.com/investor-center/.

Management will also be participating in one-on-one meetings with qualified members of the investment community throughout the conference.  For those looking to schedule one-on-one meetings with management during the H.C. Wainwright 25th Annual Global Investment Conference, please contact the Company’s investor relations firm at: SMFL@crescendo-ir.com.

About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is a high growth global leader in the Health & Wellness sector, marketing and manufacturing nutritional foods and supplements worldwide. Structured as a publicly held international holding company, the Company is executing a Buy-and-Build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues within the next thirty-six months. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition/Sports Illustrated Nutrition and Ceautamed Worldwide/Greens First. For more information about Smart for Life, please visit: For more information about Smart for Life, please visit: www.smartforlifecorp.com.

Video regarding the Company’s manufacturing facility at Bonne Santé Natural Manufacturing is available at: www.bonnesantemanufacturing.com/video.

Investor material and a Fact Sheet with additional information about Smart for Life is available at: www.smartforlifecorp.com/investor-center.

Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Disclaimer
The information provided in this press release is intended for general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. This information is not intended to diagnose, treat, cure or prevent any disease.

Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com

Advisory Board to Serve as “Brain Trust” for the Company

Miami, FL – August 2, 2023 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, announced today that it has formed a high-level advisory board to advance the commercial roll-out of its growing portfolio of health and wellness products. Sarah A. Sporn, Ph.D., has been named Chairwoman.

The board’s responsibilities will include input to the Smart for Life Board of Directors and senior management of the Company on product development and testing, brand marketing, corporate restructuring, advising on prospective M&A transactions, networking and corporate messaging.

Sarah Sporn, Ph.D., will serve as the Chairwoman of Smart for Life’s advisory board. Dr. Sporn is a scientist with a Doctorate in Microbiology and Immunology and a Bachelor of Science degree in Microbiology. Her accomplishments in biotechnology include R&D, operations and project management, as well as serving as director of a biological reagent laboratory providing high-quality biological and biochemical extracts and purified products to pharmaceutical companies. In addition, Dr. Sporn is a skilled writer, having published numerous scientific research articles and submitted successful grant proposals, having been issued a U.S. patent (co-inventor), as well as having presented at national and international scientific conferences.

Additional advisory board members include:

• Barry T. Cervantes, retired insurance industry principal, Certified Life Coach and experienced board director;
• Philip C. Meade, CPA, managing CPA partner of Bisselle Meade & Company LLP;
• Ryan S. Hazel, M.S., Global Chief Engineer at Ford Motor Company;
• Thomas Calkins, insurance executive and real estate developer;
• Steven R. Straub, financier and investor;
• Richard Cohen, investor, experienced board director, advisor, former CPA

“Formation of this advisory board is an important milestone for Smart for Life,” said Darren Minton, CEO for the Company. “We have enlisted a highly competent group of industry leaders with exceptionally diversified backgrounds, all of whom have been quite successful in their respective fields. Their backgrounds range from a doctorate in microbiology and immunology to a certified life coach, from a successful insurance executive to a global chief engineer at a top automotive company.”

A.J. Cervantes, Executive Chairman of the Company, further noted, “This advisory board is a compilation of renowned executives that will act as a sounding board and support strategic initiatives aimed at rapidly scaling businesses. A well-structured advisory board with best practice principles allows people in the organization to test their strategic thinking and access expertise or connections that may not be readily available via other means.”

Mr. Minton concluded, “The purpose of most advisory boards is to help an organization gain new insights and advice to solve business problems or explore new opportunities by stimulating robust, high-quality conversations. The role of an advisory board is not to make decisions, but rather to provide current knowledge, critical thinking and analysis to increase the confidence of the decision-makers who represent the company. We look forward to working closely with the advisory board to further advance our Company.”

About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on health and wellness. Structured as a publicly held global holding company, the Company is executing a Buy-and-Build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues by the fourth quarter of 2026. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition and Ceautamed Worldwide. For more information about Smart for Life, please visit: www.smartforlifecorp.com.

Video regarding the Company’s manufacturing facility at Bonne Santé Natural Manufacturing is available at: www.bonnesantemanufacturing.com/video.

Investor material and a Fact Sheet with additional information about Smart for Life is available at: www.smartforlifecorp.com/investor-center.

Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Disclaimer
The information provided in this press release is intended for general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. This information is not intended to diagnose, treat, cure or prevent any disease.

Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com